Agios Pharmaceuticals (AGIO) Preferred Shares (2012 - 2013)

Agios Pharmaceuticals (AGIO) reported Preferred Shares of $5.7 million for Q3 2013, down 82.7% quarter-over-quarter from $32.9 million in Q2 2013.

Agios Pharmaceuticals (AGIO) Preferred Shares (2012 - 2013) Analysis & Trends

Agios Pharmaceuticals has reported Preferred Shares for 2 years, with the latest figure at $5.7 million in Q3 2013.

For the quarter ending Q3 2013, Preferred Shares changed N/A year-over-year to $5.7 million; the trailing twelve-month figure through Sep 2013 stood at $5.7 million (changed N/A YoY), and the FY2012 full-year result was $77.3 million, changed N/A from the prior year.
Preferred Shares for Q3 2013 stood at $5.7 million, down from $32.9 million in the prior quarter.
The five-year high for Preferred Shares was $77.3 million in Q4 2012, with the low at $5.7 million in Q3 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Agios Pharmaceuticals	2.01 Bn	2.01 Bn	19.43 Mn	-

Download Data